04087 Acquired erythropoietic protoporphyria due to myelodysplastic syndrome

spontaneously decreased after a few days of treatment.Moreover, at several blood tests after drug withdrawal, the enzymes remained persistently altered.This clinical case reminds us of the importance of an accurate differential diagnosis in properly assisting the patient, especially in rare diseases for which knowledge is limited.

Authors

Gayle Ross (ORCID: https://orcid.org/0000-0001-5750-1920)

Institutions

The Royal Melbourne Hospital (AU)
The University of Melbourne (AU)

Publication Details

Published: 2024-09-01
DOI: https://doi.org/10.1136/bmjgast-2024-icpp.83
Primary Topic: Porphyrin Metabolism and Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

04087 Acquired erythropoietic protoporphyria due to myelodysplastic syndrome

Gayle Ross

Sep 1, 2024

Porphyrin Metabolism and Disorders

article

04087 Acquired erythropoietic protoporphyria due to myelodysplastic syndrome

Gayle Ross

September 1, 2024article en

Abstract

The Royal Melbourne Hospital (AU), The University of Melbourne (AU)

Openalex Percentile: Top 86%

Porphyrin Metabolism and Disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

04087 Acquired erythropoietic protoporphyria due to myelodysplastic syndrome — Gayle Ross · (2024) | TGRS Research Map | TGRS